These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27218144)

  • 1. Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury.
    Qu B; Xing R; Wang H; Chen X; Ge Q; Peng D; Wang G
    Xenobiotica; 2017 Apr; 47(4):290-296. PubMed ID: 27218144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exposure-effect-toxicity correlation of docetaxel and magnesium isoglycyrrhizinate in non-small cell lung tumor-bearing mice.
    Li P; Li S; Gu H; Lu Q; Jiang W; Pei X; Sun Y; Xu H; Wang G; Hao K
    Biomed Pharmacother; 2018 Jan; 97():1000-1010. PubMed ID: 29136767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury.
    Zou X; Wang Y; Peng C; Wang B; Niu Z; Li Z; Niu J
    Int J Mol Med; 2018 Oct; 42(4):2020-2030. PubMed ID: 30066834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects against and potential mechanisms underlying the effect of magnesium isoglycyrrhizinate in hypoxia-reoxygenation injury in rat liver cells.
    Zheng J; Wu G; Hu GX; Peng YZ; Xiong XJ
    Genet Mol Res; 2015 Dec; 14(4):15453-61. PubMed ID: 26634511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function.
    Tang GH; Yang HY; Zhang JC; Ren JJ; Sang XT; Lu X; Zhong SX; Mao YL
    World J Gastroenterol; 2015 Nov; 21(43):12370-80. PubMed ID: 26604644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
    Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
    IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium isoglycyrrhizinate ameliorates concanavalin A-induced liver injury via the p38 and JNK MAPK pathway.
    Gao Y; Tian Y; Zhang X; Zhang X; Duan Z; Ren F; Chen Y
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):445-455. PubMed ID: 32787473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes.
    Chen C; Liu YH; Cheng SB; Wu SL; Zhai XJ
    Pathol Res Pract; 2020 Apr; 216(4):152875. PubMed ID: 32113793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium isoglycyrrhizinate ameliorates lipopolysaccharide-induced liver injury by upregulating autophagy and inhibiting inflammation via IL-22 expression.
    Zhou X; Li X; Yi K; Liang C; Geng S; Zhu J; Xie C; Zhong C
    Bioorg Chem; 2022 Nov; 128():106034. PubMed ID: 35908353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of Ethanol-Induced Hepatitis by Magnesium Isoglycyrrhizinate through Inhibition of Neutrophil Cell Infiltration and Oxidative Damage.
    Wang Y; Zhang Z; Wang X; Qi D; Qu A; Wang G
    Mediators Inflamm; 2017; 2017():3526903. PubMed ID: 28951632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy.
    Fan Z; Li Y; Chen S; Xu L; Tian Y; Cao Y; Pan Z; Zhang X; Chen Y; Ren F
    Front Pharmacol; 2021; 12():794319. PubMed ID: 35058778
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury.
    Xia Y; Shi H; Qian C; Han H; Lu K; Tao R; Gu R; Zhao Y; Wei Z; Lu Y
    Front Immunol; 2022; 13():874878. PubMed ID: 35634319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities.
    Lu L; Hao K; Hong Y; Liu J; Zhu J; Jiang W; Zhu Z; Wang G; Peng Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.
    van Zuylen L; Verweij J; Nooter K; Brouwer E; Stoter G; Sparreboom A
    Clin Cancer Res; 2000 Jul; 6(7):2598-603. PubMed ID: 10914699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of magnesium isoglycyrrhizinate in rats on lung injury induced by paraquat poisoning.
    Xiao ZW; Zhang W; Ma L; Qiu ZW
    Eur Rev Med Pharmacol Sci; 2014; 18(3):311-20. PubMed ID: 24563429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug-induced liver injury: A phase II trial.
    Wang Y; Wang Z; Gao M; Zhong H; Chen C; Yao Y; Zhang Z; Zhang X; Li F; Zhang J; Gu HM; Chen Y; Tang J; Zhong W; Zeng M; Mao Y
    Liver Int; 2019 Nov; 39(11):2102-2111. PubMed ID: 31379118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.
    van Waterschoot RA; Lagas JS; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Song JY; Rooswinkel RW; van Tellingen O; Rosing H; Beijnen JH; Schinkel AH
    Cancer Res; 2009 Dec; 69(23):8996-9002. PubMed ID: 19920203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms.
    Xu Q; Wang J; Chen F; Lin K; Zhu M; Chen L; Zhou X; Li C; Zhu H
    Int J Mol Med; 2016 Jul; 38(1):275-82. PubMed ID: 27220460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential proteomic screening of plasma exosomes before and after magnesium isoglycyrrhizinate treatment in chronic hepatitis B].
    Xiao EH; Hu SW; Ning HB; Kang YH; Yin H; Mao ZS; Kang Y; Shang J
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar; 29(3):246-252. PubMed ID: 33902192
    [No Abstract]   [Full Text] [Related]  

  • 20. A narrative review of COVID-19: magnesium isoglycyrrhizinate as a potential adjuvant treatment.
    Tang C; Ding H; Sun Y; Han Z; Kong L
    Ann Palliat Med; 2021 Apr; 10(4):4777-4798. PubMed ID: 33894736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.